Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021
NCT ID: NCT05087355
Last Updated: 2021-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
440000 participants
OBSERVATIONAL
2016-01-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome.
NCT01343979
SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)
NCT04738695
Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
NCT05545332
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection
NCT04527614
Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration
NCT04627623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Influenza
PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Covid 19
PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Control group
hospitalisation due to other disease (not influenza or Covid 19)
PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with Covid-19
* Patients after Covid-19
* Patients with influenza
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Landesklinikum Sankt Polten
OTHER
Sicknessfund Burgenland (BGKK)
UNKNOWN
A.รถ. Krankenhaus St. Josef Braunau GmbH
OTHER
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hendrik Jan Ankersmit
Principal Investigator/Univ. Prof. , MD, MBA
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUTCOV-INFLU-STUDY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.